We are live on ! Find out more
XBIT icon

XBiotech
XBIT

56 hedge funds and large institutions have $18.9M invested in XBiotech in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

2.21% less ownership

Funds ownership: 13.25% → 11.04% (-2.2%)

13% less funds holding

Funds holding: 64 → 56 (-8)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

46% less capital invested

Capital invested by funds: $34.9M → $18.9M (-$15.9M)

70% less call options, than puts

Call options by funds: $7K | Put options by funds: $23K

Holders
56
Holders Change
-8
Holders Change %
-12.5%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
17
Reduced
17
Closed
21
Calls
$7K
Puts
$23K
Net Calls
-$16K
Net Calls Change
-$27K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.8M
2
Morgan Stanley
Morgan Stanley
New York
+$1.11M
3
OMC
Oasis Management Company
Cayman Islands
+$923K
4
Renaissance Technologies
Renaissance Technologies
New York
+$529K
5
CS
Credit Suisse
Switzerland
+$473K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$5.21M
2
State Street
State Street
Massachusetts
-$1.79M
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$977K
4
Nuveen
Nuveen
North Carolina
-$764K
5
Allspring Global Investments
Allspring Global Investments
North Carolina
-$763K

XBIT Hedge Fund Activity: Q2 2022 in Review

56 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q2 2022, worth a combined $18.9M — down 46% from $34.9M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of XBIT and 14 opened new positions — a net loss of 7 holders — while 17 trimmed existing stakes and 17 added.

The largest buyer was Millennium Management, adding an estimated $1.8M. The largest seller was BlackRock, cutting an estimated $5.21M.

  • 56 institutional investors held XBiotech (XBIT) as of Q2 2022, down from 64 in Q1 2022.
  • Funds reported $18.9M of XBiotech stock for Q2 2022, down 46% quarter-over-quarter.
  • 14 funds opened new XBiotech positions in Q2 2022 and 21 closed out, a net change of -7 holders.
  • The largest XBiotech buyer in Q2 2022 was Millennium Management, an estimated $1.8M added.
  • The largest XBiotech seller in Q2 2022 was BlackRock, an estimated $5.21M sold.

Based on aggregated 13F filings for Q2 2022.